European Cancer Forum 2025: Innovation, Security and Sustainability
DUO-O trial: Durvalumab + Bevacizumab + Olaparib Improves PFS in Newly Diagnosed BRCA-Wild-Type Ovarian Cancer
10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
A New Invention: Nanoparticle-Based Salivary Biosensor for Early Detection of Oral Squamous Cell Carcinoma
CancerWorld Issue #110 (December) is Live
Tanja Obradovic: Eventful 2025 Year for Cancer Drugs-45 New or Accelerated Approvals by FDA
Advancing Childhood Cancer Care at the 2025 St. Jude Global Alliance Convening
Samra Turajlić: Honoured to Receive the 2026 Pezcoller–EACR Translational Cancer Award
The ESMO Course in Medical Oncology for Medical Students 2026 is an interactive, four-day residential educational program taking place from July 24 to 28, 2026, in Valencia, Spain. Organized by […]
The Molecular Analysis for Precision Oncology (MAP) Congress 2026, co-organized by the European Society for Medical Oncology (ESMO), Cancer Research UK (CRUK), and Unicancer, is scheduled for 10–11 September 2026 […]
The ESMO Congress 2026 will take place from 23–27 October in Madrid, Spain, bringing together oncology professionals from around the world. This global event serves as a key platform for […]
The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18, 2026, in Berlin, Germany. This congress is designed as a central meeting point that facilitates the […]
The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO), scheduled for December 14–16, 2026, as an onsite event in London, […]
The ESMO Congress 2027 will take place in Barcelona, Spain, from September 17–21, 2027. This event is recognized as a leading global oncology meeting that serves as a platform for […]